Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Dr Naval Daver discusses the use of nivolimumab and ipilimumab in combination with azacitidine in myelodysplastic syndrome and acute myeloid leukemia. FILMED AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING 2016, SAN DIEGO, CALIFORNIA, US
Adding a second agent to azacitidine for older patients with high-risk myelodysplastic syndrome (MDS) was not found to improve outcomes in the North American Intergroup MDS study, according to Dr Sekeres (Cleveland Clinic, Cleveland, USA) who talked to ecancertv at ASH 2014 about this phase II randomised trial.
Dr. Valeria Santini expounds upon how to understand the efficacy of azacitidine in different myelodysplastic syndromes' (MDS) subgroups.